☆ 4.2 Article

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis Data from Six Clinical and Phase I Safety Studies

CLINICAL DRUG INVESTIGATION (2010)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis Data from Six Clinical and Phase I Safety Studies

Rate this paper

Discover Peeref hubs

Create your own webinar

Export Citation

Share Paper